Clinical Trial Update: Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating erenumab-aooe (Aimovig) effect on disability and work productivity in employed individuals with episodic migraine; study TERMI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Erenumab-aooe (erenumab-aooe)

Snippet

Sponsor: Amgen | Conditions: Migraine | Phase 4 | Status: TERMINATED | Results posted: 2022-07-20